The Plasticity of Immune Cell Response Complicates Dissecting the Underlying Pathology of Multiple Sclerosis

Sujan Kumar Sarkar,Annie M. L. Willson,Margaret A. Jordan

DOI: https://doi.org/10.1155/2024/5383099

IF: 4.4929

2024-01-05

Journal of Immunology Research

Abstract:Multiple sclerosis (MS) is a neurodegenerative autoimmune disease characterized by the destruction of the myelin sheath of the neuronal axon in the central nervous system. Many risk factors, including environmental, epigenetic, genetic, and lifestyle factors, are responsible for the development of MS. It has long been thought that only adaptive immune cells, especially autoreactive T cells, are responsible for the pathophysiology; however, recent evidence has indicated that innate immune cells are also highly involved in disease initiation and progression. Here, we compile the available data regarding the role immune cells play in MS, drawn from both human and animal research. While T and B lymphocytes, chiefly enhance MS pathology, regulatory T cells (Tregs) may serve a more protective role, as can B cells, depending on context and location. Cells chiefly involved in innate immunity, including macrophages, microglia, astrocytes, dendritic cells, natural killer (NK) cells, eosinophils, and mast cells, play varied roles. In addition, there is evidence regarding the involvement of innate-like immune cells, such as γδ T cells, NKT cells, MAIT cells, and innate-like B cells as crucial contributors to MS pathophysiology. It is unclear which of these cell subsets are involved in the onset or progression of disease or in protective mechanisms due to their plastic nature, which can change their properties and functions depending on microenvironmental exposure and the response of neural networks in damage control. This highlights the need for a multipronged approach, combining stringently designed clinical data with carefully controlled in vitro and in vivo research findings, to identify the underlying mechanisms so that more effective therapeutics can be developed.

immunology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the complexity of the pathological mechanism of multiple sclerosis (MS), especially the role of immune cells in the development of the disease. MS is a chronic inflammatory disease of the central nervous system (CNS), characterized by the destruction of the myelin sheath of nerve axons, leading to the loss of nerve function. Although it has long been believed that only adaptive immune cells, especially autoreactive T - cells, are responsible for its pathophysiological processes, recent studies have shown that innate immune cells also play an important role in the initiation and development of the disease.

The paper specifically discusses the following points:

1. **Role of immune cells**: The paper reviews the roles of different types of immune cells in MS, including T - cells, B - cells, regulatory T - cells (Tregs), macrophages, microglia, astrocytes, dendritic cells, natural killer cells (NK cells), eosinophils and mast cells, etc. These cells may promote or inhibit the development of MS at different stages.

2. **Cell plasticity**: The plasticity of immune cells increases the difficulty in understanding the pathological mechanism of MS. The properties and functions of these cells change according to the changes in the microenvironment, which makes it complicated to determine which cell subsets are involved in the initiation, progression or protection mechanisms of the disease.

3. **Differences between early and late - stage MS**: The paper also discusses the differences between early - stage MS and late - stage MS (such as secondary progressive MS, SPMS), and how these differences affect the choice of treatment strategies.

4. **Treatment challenges**: Due to the complexity and plasticity of immune cells, developing effective treatment methods faces huge challenges. The paper emphasizes the need to combine clinical data and the results of strictly controlled in - vitro and in - vivo studies to identify potential treatment targets, so as to develop more effective treatment regimens.

Through these discussions, the paper aims to reveal the complexity of the pathological mechanism of MS and provide directions for future treatment research.